TITLE

Can the burden of pneumonia among HIV-infected children be reduced?

AUTHOR(S)
Jeena, Prakash Mohan
PUB. DATE
May 2008
SOURCE
Bulletin of the World Health Organization;May2008, Vol. 86 Issue 5, p323
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the possible mitigation of pneumonia to the children with human immunodeficiency virus (HIV) in Africa. It mentions that there are about 2.1 million children who are suffering HIV and 80% of them are suffering the burden of pneumonia. According to the World Health Organization (WHO) that there are 20% to 34% of African children with HIV died due to pneumonia and the fatality rates are three to six times higher than those children who are not infected with HIV. However, according to the author, vaccination, provision of cotrimoxazole, and highly active anti retroviral therapy could possibly reduce the burden of pneumonia.
ACCESSION #
32040550

 

Related Articles

  • Newer pneumococcal vaccine rouses immune response in adults with HIV.  // HIV Treatment ALERTS!;Sep2015, p35 

    The article discusses the impact of pneumococcal vaccine on the immune response of people with human immunodeficiency virus (HIV). Topics covered include the effect of pneumoniae on patients with HIV. Also mentioned are the invasion of the bacteria in the spinal fluid or blood of patients.

  • Get Your Pneumonia Shot. Helquist, Michael // Advocate;3/28/89, Issue 521, p24 

    Reports on the U.S. Centers for Disease Control & Prevention's recommendation for HIV infected persons to obtain vaccination against streptococcus pneumonia. Available vaccines for the condition.

  • Combining TB and HIV treatment to save lives.  // WHO Drug Information;2004, Vol. 18 Issue 4, p293 

    Reports on the combination of TB and HIV interventions in saving the lives of HIV infected people. Significance of joint TB and HIV treatment; Effectiveness of the combined TB and HIV interventions; Prognosis of people given with combined TB and HIV treatment that people with single treatment only.

  • Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Campos, Pablo E.; Suarez, Pedro G.; Sanchez, Jorge; Zavala, David; Arevalo, Jorge; Ticona, Eduardo; Nolan, Charles M.; Hooton, Thomas M.; Holmes, King K. // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1571 

    During 1999 to 2000, we identified HIV-infected persons with new episodes of tuberculosis (TB) at 10 hospitals in Lima, Peru, and a random sample of other Lima residents with TB. Multidrug-resistant (MDR)-TB was documented in 35 (43%) of 81 HIV-positive patients and 38 (3.9%) of 965 patients...

  • Abacavir.  // Reactions Weekly;10/13/2007, Issue 1173, p4 

    The article discusses a case of abacavir-induced acute fibrinous and organising pneumonia in a 52-year-old woman with HIV. The symptoms manifested two weeks after taking abacavir along with other drugs such as lamivudine and atazanavir. She eventually developed immune reconstitution inflammatory...

  • H1N1pdm09 Adjuvanted Vaccination in HIV-Infected Adults: A Randomized Trial of Two Single versus Two Double Doses Santini-Oliveira, Marilia; Camacho, Luiz A. B.; Souza, Thiago M. L.; Luz, Paula M.; Vasconcellos, Mauricio T. L.; Giacoia-Gripp, Carmem B. W.; Morgado, Mariza G.; Nunes, Estevão P.; Lemos, Alberto S.; Ferreira, Ana C. G.; Moreira, Ronaldo I.; Veloso, Valdiléa G.; Siqueira, Marilda M.; Grinsztejn, Beatriz // PLoS Clinical Trials;Jun2012, Vol. 7 Issue 6, p1 

    Background: Since human immunodeficiency virus (HIV)-infected individuals are at increased risk of severe disease from pandemic influenza A (H1N1pdm09), vaccination was recommended as a prevention strategy. The aim of the present study was to evaluate the safety, immunogenicity and persistence...

  • HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). Meiring, Susan; Cohen, Cheryl; Quan, Vanessa; de Gouveia, Linda; Feldman, Charles; Karstaedt, Alan; Klugman, Keith P.; Madhi, Shabir A.; Rabie, Helene; Sriruttan, Charlotte; von Gottberg, Anne; null, null // PLoS ONE;2/10/2016, Vol. 11 Issue 2, p1 

    Introduction: Streptococcus pneumoniae is the commonest cause of bacteremic pneumonia among HIV-infected persons. As more countries with high HIV prevalence are implementing infant pneumococcal conjugate vaccine (PCV) programs, we aimed to describe the baseline clinical characteristics of adult...

  • Effect of Pneumococcal Vaccine on Plasma HIV-1 RNA of Stable Patients Undergoing Effective Highly Active Antiretroviral Therapy. Negredo, E.; Domingo, P.; Sambeat, M. A.; Rabella, N.; Vázquez, G. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2001, Vol. 20 Issue 4, p287 

    The article reports on a study analyzing the effect of pneumococcal vaccine on plasma HIV-1 RNA of stable patients undergoing effective highly active antiretroviral therapy. Unchanged levels of plasma HIV-1 RNA after immunization in untreated patients have also been documented in this article....

  • Updated meningococcal vaccine policy.  // Clinical Advisor;Jan2012, Vol. 15 Issue 1, p16 

    The article reports on the approval of the American Academy of Pediatrics and the Advisory Community on Immunization Practices of the Centers for Disease Control and Prevention (CDC) on the use of quadrivalent meningococcal conjugate vaccines in adolescents and people with meningococcal disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics